Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Abi Berger
| The first 150 words of the full text of this article appear below. |
Good direct evidence that the body's inability to clear up cell debris leads to systemic lupus erythematosus (SLE) has been confirmed by German scientists.
Cell biologists have confirmed that a lack of DNase1, an enzyme that degrades DNA, leads to the development of SLE. Their finding is not only important in understanding the pathogenesis of SLE, but also suggests that detection of high risk cases may be possible. Early diagnosis may also allow treatment with compounds containing DNase1 as a useful adjunct to conventional treatment with immunosuppressive drugs (Nature Genetics 2000;25:177-81).
This enzyme is secreted in bodily fluids and tends to be active at sites of cell destruction. It is responsible for clearing up cellular debris and does so by chopping up long strands of DNA into short pieces to facilitate their disposal.
While trying to elucidate some of the processes involved in apoptosis
(programmed cell death), Professor Tarik Mïrïy
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.